Piramal Shunning Bankers Show India Challenge for Fees

Indian billionaire Ajay Piramal may spend $1 billion to acquire biotechnology and defense assets for his health care-to-real estate empire. Investment bankers are unlikely to get a share of that money.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.